HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.

Abstract
The artemisinins have become key drugs for the treatment and control of malaria, particularly within artemisinin-based combination therapies. Since the artemisinins also exhibit antischistosomal properties, their use in areas where malaria and schistosomiasis are co-endemic may have an effect on both diseases and co-infection might alter drug efficacy. We assessed the antimalarial and antischistosomal efficacies of artemether in mice infected with Plasmodium berghei or Schistosoma mansoni or both parasites concurrently. Three oral doses of 400 mg/kg artemether at 14-day intervals reduced total and female S. mansoni worm burdens by 98.7-100%, regardless of a concurrent P. berghei infection. When four daily doses of 55 mg/kg artemether were administered, which is a standard treatment schedule to cure P. berghei-infected mice, significantly lower total and female S. mansoni worm burden reductions were observed (73.1-89.2%). Artemether, administered at both of the above-mentioned treatment schemes, showed excellent antimalarial efficacy with no indications of delayed clearance of P. berghei or recrudescence, also in mice co-infected with S. mansoni. Co-infection with P. berghei had no effect on S. mansoni worm burden reductions following artemether-praziquantel combinations. Our findings point to the need for epidemiological studies in areas where malaria and schistosomiasis co-exist and where artemisinin-based combination therapies are introduced, since artemisinin-based combination therapies as part of a malaria control package may have ancillary benefits against schistosomiasis.
AuthorsXiao Shu-Hua, Jürg Utzinger, Jacques Chollet, Marcel Tanner
JournalInternational journal for parasitology (Int J Parasitol) Vol. 36 Issue 8 Pg. 957-64 (Jul 2006) ISSN: 0020-7519 [Print] England
PMID16750833 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimalarials
  • Artemisinins
  • Schistosomicides
  • Praziquantel
  • Artemether
Topics
  • Animals
  • Antimalarials (pharmacology)
  • Artemether
  • Artemisinins (pharmacology)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Intestines (parasitology)
  • Liver (parasitology)
  • Malaria (complications, drug therapy, parasitology)
  • Mice
  • Parasitemia (drug therapy, parasitology)
  • Plasmodium berghei (growth & development)
  • Praziquantel (pharmacology)
  • Schistosoma mansoni (growth & development)
  • Schistosomiasis mansoni (complications, drug therapy, parasitology)
  • Schistosomicides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: